ACXP
Acurx Pharmaceuticals LLC
NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY
$2.16
+0.00% today
Updated 2026-05-01
Market cap
$5.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.32
Dividend yield
—
52W range
$1 – $21
Volume
3.8M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$17.00
+687.04%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.18M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-12.09M | $-14.58M | $-14.10M | $-7.97M | $-1.58M |
| EPS | — | — | — | — | $-5.32 |
| Free cash flow | $-7.54M | $-9.80M | $-10.38M | $-6.79B | $-1.18M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Acurx Pharmaceuticals LLC trades at $2.16. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Acurx Pharmaceuticals LLC's stock price?
Acurx Pharmaceuticals LLC (ACXP) trades at $2.16.
Is Acurx Pharmaceuticals LLC overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Acurx Pharmaceuticals LLC (ACXP)?
The analyst target price is $17.00, representing +687.0% upside from the current price of $2.16.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-270.80%
Beta-1.92
50D MA$2.97
200D MA$4.16
Shares out0.00B
Float0.00B
Short ratio—
Avg volume3.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—